Lipocine (LPCN) SEC Filings & 10K Form

$5.37
+0.02 (+0.37%)
(As of 10:48 AM ET)

Recent Lipocine SEC Filings

DateFilerForm TypeView
05/09/2024
5:03 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
5:06 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
5:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM
Lipocine (Filer)
Form 424B5
04/26/2024
4:20 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
11:15 PM
Lipocine (Filer)
Form EFFECT
04/23/2024
3:24 PM
Lipocine (Filer)
Form S-3/A
04/23/2024
3:05 PM
Lipocine (Filer)
Form DEF 14A
04/11/2024
6:24 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
5:26 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
5:14 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
4:51 PM
Fogarty Krista (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:53 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:31 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
5:07 AM
Lipocine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
5:08 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
5:01 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
7:20 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
9:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
3:15 PM
Lipocine (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/13/2023
1:45 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
12:15 PM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
8:50 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
8:31 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2023
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
7:52 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
3:05 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
7:31 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
7:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2023
5:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
8:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
8:20 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
3:19 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
7:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2023
7:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
3:49 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2023
2:10 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
6:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:LPCN) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners